Clinical Trial Detail

NCT ID NCT03441555
Title A Study of Venetoclax and Alvocidib in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors AbbVie
Indications

acute myeloid leukemia

Therapies

Alvocidib + Venetoclax

Age Groups: adult senior

No variant requirements are available.